Nine Masts Capital LTD Astrazeneca PLC Transaction History
Nine Masts Capital LTD
- $335 Million
- Q1 2025
A detailed history of Nine Masts Capital LTD transactions in Astrazeneca PLC stock. As of the latest transaction made, Nine Masts Capital LTD holds 184 shares of AZN stock, worth $12,661. This represents 0.01% of its overall portfolio holdings.
Number of Shares
184Holding current value
$12,661% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding AZN
# of Institutions
1,426Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.93 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.8 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.45 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.19 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.15 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $213B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...